By restricting our analysis to CMF–treated patients only, we find that the relation between BRCA1 methylation and breast cancer–specific survival holds statistical significance (HR = 0.11, 95% CI = 0.014 to 0.81, P = .03). The gene discussed is BRCA1; the disease is breast carcinoma.